Glycated albumin and HbA1c as markers of lower extremity disease in US adults with and without diabetes
- 20 January 2022
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 184, 109212
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Use and Utility of Ankle Brachial Index in Patients with DiabetesEuropean Journal of Vascular and Endovascular Surgery, 2011
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Comprehensive Foot Examination and Risk AssessmentDiabetes Care, 2008
- Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or olderDiabetes Research and Clinical Practice, 2007
- Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trialsAmerican Heart Journal, 2006
- Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among menThe American Journal of Medicine, 2004
- Diabetes control and complications: the role of glycated haemoglobin, 25 years onDiabetic Medicine, 2003
- Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.Diabetes Care, 1999
- Diabetic peripheral neuropathy: Effects of age, duration of diabetes, glycemic control, and vascular factorsJournal of Diabetes and its Complications, 1997